相关实验视频

Updated: Jun 27, 2025

Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System

Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System

Published on: October 4, 2024

计算应用:波韦从菌毒素变成人性化药物

Charbel Al Khoury¹, Sima Tokajian², Nabil Nemer³

¹Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, Beirut Campus, P.O. Box 13-5053, Chouran, Beirut 1102 2801, Lebanon.

|April 26, 2024

概括

博韦里辛 (BEA) 是一种真菌毒素,显示出作为各种疾病治疗剂的潜力. 在探索BEA时,in silico方法至关重要.

科学领域:

药物的发现和开发.
计算化学是一种计算化学.
菌类学菌类学是指菌类学.

背景情况:

传统药物发现是昂贵和耗时的.
包括分子对接在内的in silico建模正在彻底改变药物发现.
一种真菌毒素贝奥维里辛 (BEA) 正在被研究用于制药应用.

研究的目的:

为了提供一个概述的 Beauvericin (BEA) 重新用于治疗应用.
突出"in silico"技术在药物发现中的作用.
调查BEA的活动范围和行动方式.

主要方法:

在模型建模.
分子对接是分子对接.
分子动力学模拟的模拟.

主要成果:

在基技术预测药物和目标之间的生物分子相互作用.
BEA显示出作为治疗剂的重新利用的潜力.
计算方法有助于理解BEA的活动和机制.

结论:

在Silico方法对于有效的药物重新利用至关重要.
BEA是开发新疗法的一个有前途的候选者.
使用计算方法进行进一步的研究将揭示BEA的全部潜力.

关键词:

贝奥维里辛 (Beavericin) 是一种可怕的药物.计算机辅助的药物发现.菌类毒素 (mycotoxin) 是一种有毒的物质.自然化合物自然化合物重新调整使用目的.

更多相关视频

Transformation of Probiotic Yeast and Their Recovery from Gastrointestinal Immune Tissues Following Oral Gavage in Mice

Transformation of Probiotic Yeast and Their Recovery from Gastrointestinal Immune Tissues Following Oral Gavage in Mice

Published on: February 8, 2016

An Improved Protocol to Purify and Directly Mono-Biotinylate Recombinant BDNF in a Tube for Cellular Trafficking Studies in Neurons

An Improved Protocol to Purify and Directly Mono-Biotinylate Recombinant BDNF in a Tube for Cellular Trafficking Studies in Neurons

Published on: July 11, 2020

相关概念视频

Drug Biotransformation: Overview

Drug Biotransformation: Overview

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...